| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AIM over the last quarter tilts toward buying: insiders added a net 94,150 shares worth roughly $19K. In the past 30 days, 1 insider bought and 0 sold. Purchases have clustered in the most recent filings.
Equels Thomas K (CEO &President) stands out among recent buyers, now holding an estimated $26K in AIM. A senior officer buying with their own money is generally read as a stronger signal than routine insider selling.
Classified under Biotechnology (Health Care sector), AIM's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 158.1K | $25.8K | +31.3K | |
| Dir | 28.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 500 | $0.09 | $43.50 | +0.1% | -1.7% | -93.2% | |
| Apr 4, 2025 | Equels Thomas K | CEO &President | Buy | 41,000 | $0.06 | $2,583.00 | +2.2% | -1.7% | -93.2% | |
| Mar 5, 2025 | Equels Thomas K | CEO &President | Buy | 50,000 | $0.13 | $6,730.00 | +2.8% | -38.5% | -94.9% | |
| Mar 4, 2025 | Equels Thomas K | CEO &President | Buy | 44,000 | $0.12 | $5,060.00 | +2.5% | -41.7% | -94.1% | |
| Mar 4, 2025 | Equels Thomas K | CEO &President | Buy | 83,334 | $0.12 | $10,000.08 | +5.0% | -41.7% | -94.1% | |
| Dec 19, 2024 | Mitchell William M | Director | Sell | 4,580 | $0.19 | $883.94 | -3.7% | -36.8% | -92.5% | |
| Dec 18, 2024 | Equels Thomas K | CEO &President | Buy | 22,727 | $0.21 | $4,681.76 | +1.4% | -40.0% | -93.2% | |
| Dec 2, 2024 | Appelrouth Stewart | Director | Buy | 11,112 | $0.21 | $2,355.74 | +3.2% | -45.5% | -93.7% | |
| Nov 21, 2024 | Equels Thomas K | CEO &President | Buy | 20,000 | $0.21 | $4,240.00 | +1.2% | -38.1% | -93.5% | |
| Nov 20, 2024 | Equels Thomas K | CEO &President | Buy | 85,000 | $0.20 | $16,915.00 | +5.5% | -30.0% | -93.5% |